| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Recursion Pharmaceuticals, Inc. (RXRX) have been net sellers, shedding 127,408 shares worth roughly $546K on balance. In the past 30 days, 0 insiders bought and 2 sold. The bias lately has been to the sell side.
All 2 insiders who sold still hold shares after their sales. RXRX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.11M | $29.56M | -50,000 | |
| CEO | 2.07M | $7.29M | - | |
| Dir | 1.48M | - | - | |
| CFO | 1.07M | $3.65M | - | |
| Other | 1.04M | $3.30M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2024 | Borgeson Blake68 | Director | Sell10b5-1 | 11,447 | $7.95 | $90,963.59 | -0.2% | +4.7% | -28.5% | |
| Apr 25, 2024 | Marriott Tina73 | President and COO | Sale+OE10b5-1 | 3,000 | $7.67 | $23,020.50 | -0.5% | -0.4% | -26.9% | |
| Apr 17, 2024 | Secora Michael74 | Chief Financial Officer | Sale+OE10b5-1 | 48,124 | $7.63 | $367,006.79 | -3.8% | +15.1% | -26.4% | |
| Apr 16, 2024 | Borgeson Blake68 | Director | Sell10b5-1 | 11,447 | $7.66 | $87,725.23 | -0.2% | +8.3% | -29.7% | |
| Apr 4, 2024 | Gibson Christopher71 | Chief Executive Officer | Sell10b5-1 | 130,000 | $8.93 | $1,160,900.00 | - | -15.8% | -51.4% | |
| Apr 2, 2024 | Borgeson Blake68 | Director | Sell10b5-1 | 11,447 | $8.82 | $100,941.94 | -0.2% | -14.9% | -39.7% | |
| Mar 28, 2024 | Gibson Christopher71 | Chief Executive Officer | Sale+OE10b5-1 | 65,000 | $10.10 | $656,500.00 | - | -12.1% | -41.7% | |
| Mar 21, 2024 | Marriott Tina73 | President and COO | Sale+OE10b5-1 | 8,000 | $10.75 | $85,979.89 | -1.2% | -14.1% | -37.3% | |
| Mar 19, 2024 | Borgeson Blake68 | Director | Sell10b5-1 | 20,054 | $10.79 | $216,422.77 | -0.3% | -12.8% | -38.8% | |
| Mar 13, 2024 | Secora Michael74 | Chief Financial Officer | Sale+OE10b5-1 | 50,000 | $10.74 | $537,190.00 | -4.0% | -21.9% | -45.9% |